Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

New details emerge in Jerry Sandusky sex abuse scandal
Wal-Mart’s Total Sales Drop; The Retailer will Introduce its ‘Door-Greeter’ Prog
Two Fire Incidents in Federal Center SW Station Leads to a Shut Down
Increasing Number of Car Makers Collaborating with Tech Companies to Develop Sel
Mortgage Rates Move Back Close to Its Yearly Low
Fire threatens entire city in Alberta
George Bush to stay out of the presidential campaign
Teen Retailer Aeropostale Files for Bankruptcy Protection; Closing Twenty Percen
Zynga’s Q1 Earnings Repot Beats Analysts’ Estimates
Tribune Publishing Says ‘No’ to Gannett Company’s Takeover Offer
Tesla Motors Posts Loss in the First Quarter that’s Larger than Last Year
Syndicate content